ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sanofi to acquire Kymab for up to $1.45bn pharmatimes
January 12, 2021Sanofi will acquire Cambridge, UK-based biopharmaceutical company Kymab in a potential $1.45bn deal, which will see the French pharma add Kymab’s monoclonal antibody (mAB) KY1005 to its pipeline.
Pharma Sources Insight July 2025
